BioNTech SE (BNTX) Retained Earnings (2018 - 2025)
BioNTech SE's (BNTX) quarterly Retained Earnings came in at $20.9 billion in Q4 2025, up 2.45% year-on-year from $20.4 billion in Q4 2024, and down 2.09% quarter-over-quarter from $21.4 billion in Q3 2025.
BioNTech SE (BNTX) Retained Earnings (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Retained Earnings across 8 years of filings, most recently posting $20.9 billion for Q4 2025.
- Retained Earnings for Q4 2025 came in at $20.9 billion, up 2.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.9 billion (up 2.45% YoY), and the FY2025 annual result was $20.3 billion, down 0.56% from the prior year.
- Retained Earnings came in at $20.9 billion for Q4 2025 at BioNTech SE, down from $21.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $21.4 billion in Q3 2025 to a low of $54.4 million in Q1 2021.
- The 5-year median for Retained Earnings is $20.5 billion (2024), against an average of $18.2 billion.
- Across the five-year window, Retained Earnings soared 27920.04% in 2022 and retreated 6.99% in 2025, its largest moves.
- BioNTech SE's Retained Earnings stood at $11.3 billion in 2021, then surged by 69.95% to $19.2 billion in 2022, then gained by 10.67% to $21.3 billion in 2023, then retreated by 4.03% to $20.4 billion in 2024, then gained by 2.45% to $20.9 billion in 2025.
- The last three Retained Earnings figures came in at $20.9 billion (Q4 2025), $21.4 billion (Q3 2025), and $20.7 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 20.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.91 Bn |
| Sep 30, 2025 | 21.36 Bn |
| Jun 30, 2025 | 20.71 Bn |
| Mar 31, 2025 | 19.65 Bn |
| Dec 31, 2024 | 20.41 Bn |
| Sep 30, 2024 | 20.69 Bn |
| Jun 30, 2024 | 20.07 Bn |
| Mar 31, 2024 | 21.13 Bn |
| Dec 31, 2023 | 21.26 Bn |
| Sep 30, 2023 | 21.02 Bn |
| Jun 30, 2023 | 20.85 Bn |
| Mar 31, 2023 | 20.75 Bn |
| Dec 31, 2022 | 19.21 Bn |
| Sep 30, 2022 | 16.69 Bn |
| Jun 30, 2022 | 15.76 Bn |
| Mar 31, 2022 | 15.24 Bn |
| Dec 31, 2021 | 11.31 Bn |
| Mar 31, 2021 | 54.40 Mn |
| Dec 31, 2020 | 488.36 Mn |
| Dec 31, 2019 | -470.24 Mn |